Menu
ncarol.com
  • Home
  • Books
  • Book Release
  • Health
  • Business
  • Arts
  • Music
  • Real Estate
  • Education
ncarol.com

Lineus Medical's CEO Vance Clement joins the 2025 Association of Vascular Access Board of Directors
ncarol.com/10269488

Trending...
  • Sexually Abused in a Psychiatric Hospital or Psychiatrist's or Psychologist's Office? CCHR Urges Survivors to Reach Out to It
  • Triple-Digit Growth, Stock Market Upgrade plus a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation (Stock Symbol: CDIX)
  • AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
Lineus Medical CEO, Vance Clement AVA Logo Lineus Medical
FAYETTEVILLE, Ark. - ncarol.com -- Vance Clement, CEO of Lineus Medical, has been selected to join the Association of Vascular Access (AVA) Board of Directors as a Director at Large for a two-year term. AVA is an association of healthcare professionals whose mission is to advance the global practice of vascular access, through awareness, advocacy, and education to improve healthcare outcomes. Since 1985, they have worked to improve vascular access care and promote vascular access specialty. During Vance's time on the board, he will highlight the importance of vascular access care, provide support to local vascular access networks (VAN) across the nation, and grow AVA's membership.  When asked about being selected to join the board Vance said, "It is an honor to join the AVA Board of Directors.  I consider AVA to be the preeminent organization for anyone working in the vascular access space.  I look forward to helping AVA grow its membership."

Vance Clement has worked in the medical device industry for over 30 years. He is a frequent speaker at VAN chapter meetings across the country. He has served as the co-founder and CEO of Lineus Medical since 2015 and is passionate about improving IV care and advancing the science around IV care. Under his leadership, Lineus Medical brought the first break away device for medical lines, SafeBreak Vascular, to market.

More on ncarol.com
  • RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project
  • Web Design Evolution: How 'Lovable' AI Sites are Transforming Modern Book and Product Launches
  • 100+ Episodes In, Liftoff with Keith Newman Tells Founders to Stop Publishing More
  • Vierra Communities Adds Operations of Two Skilled Nursing Facilities in the DC Metro Area
  • Slotozilla Introduces a Centralized Resource for World Cup Bonus Offers

SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.

About Lineus Medical

Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.

1.          Data on File

MKG 0287 Rev 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • New "Lakeside Picnic Ride" Package in Japan's Lake Chuzenji region of Nikko: July 1- November 30, 2026
  • Former MP Shri GV Harsha Kumar Meets AICC President Mallikarjun Kharge
  • Two Attorneys at The Stanley Law Group Named to 2026 South Carolina Super Lawyers List
  • IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
  • Allstream Energy Partners Expands AI-Optimized Website Development Division to Meet Growing Demand in GEO / AEO Services
  • America's Workforce Solution Named an OpenAI SMB Channel Partner, Bringing Enterprise-Grade AI to Main Street
  • Data Tiles Introduces the Decision-Driven Enterprise to North America
  • FitTrace Sync 1.11 Brings Apple Health and Google Health Connect Integration Into Its Mobile App
  • Disruptor Creations Pioneers New MicroAdventure Series with TravelSpike
  • eCopier Solutions Surpasses 3,000 Five-Star Google Reviews and Maintains Perfect Five-Star Rating
  • Creative Investment Research Welcomes Supreme Court Decision Protecting Federal Reserve Independence While Calling for Continued Accountability
  • New from Regal House Publishing, The Reel Life of Zara Kegg: Love, grief, Godzilla, odd beach winter
  • Ascent Solar Technologies (N A S D A Q: ASTI): Positioned at the Intersection of the New Space Economy, Defense Innovation and Next-Generation Energy
  • Triple-Digit Growth, Stock Market Upgrade plus a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation (Stock Symbol: CDIX)
  • Morrisville & Cary Education Centers Honored with National Award
  • AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
  • Henri-Lloyd Launches Sail Free to Break Down Barriers to Sailing
  • Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Jacksonville JTB/Deerwood Park
  • Destination Niagara Launches Game Changing Digital Magazine Redefining How Visitors Experience Niagara Falls
  • Join us at Seaside Art Gallery for our July 4th celebration
_catLbl0 _catLbl1

Popular on ncarol.com

  • Kevin Francis Design Introduces CHROMA, a Collection of Saturated Solid Color Wool Rugs - 543
  • Agape Leadership Academy Opens Nationwide Enrollment — State ESA Scholarships Cover Full Tuition for Families in 7 States - 130
  • Boston Industrial Solutions Introduces New Natron® 310 Hyper White UV Ink for Enhanced Printing Performance - 114
  • UK Financial Ltd Completes One Of The Most Extensive CoinMarketCap Supply Verification Packages For Maya Preferred PRA (MPRA) - 103
  • Psychiatric Hospitals Fail to Warn Electroshock Patients of FDA-Cited Risks in Estimated $7 Billion Industry
  • Nevada Boxing Hall of Fame Announces 14th Annual Induction Gala Weekend Honoring Classes of 2025 and 2026
  • AI Is Making It Easier for API-First Platforms to Connect, Partner, Reach Customers, and Grow Revenue Faster
  • A New Pulse for Cardiac Care in Baltimore: St. Elizabeth Rehab & Nursing Welcomes Dr. Hakim Uqdah and Expands Advanced Heart Program
  • Sexually Abused in a Psychiatric Hospital or Psychiatrist's or Psychologist's Office? CCHR Urges Survivors to Reach Out to It
  • George Martinez Launches Community Re-distribution Initiative With Donation to the Gamma Alpha Alpha Chapter of Omega Psi Phi Fraternity, Inc

Similar on ncarol.com

  • Why More Phoenix Families Are Turning to Private Autopsy Services for Answers
  • RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project
  • 100+ Episodes In, Liftoff with Keith Newman Tells Founders to Stop Publishing More
  • Vierra Communities Adds Operations of Two Skilled Nursing Facilities in the DC Metro Area
  • Dentists launch independent platform to help practices choose the right technology
  • Contracting Resources Group Recognized by The Daily Record as a 2026 In the Lead: Best Women-Owned Businesses Honoree
  • IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
  • Allstream Energy Partners Expands AI-Optimized Website Development Division to Meet Growing Demand in GEO / AEO Services
  • Data Tiles Introduces the Decision-Driven Enterprise to North America
  • FitTrace Sync 1.11 Brings Apple Health and Google Health Connect Integration Into Its Mobile App
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute